Clinical Trial

Evaluate the Safety and Efficacy of HL-1186 Tablet for Postoperative Analgesia in Orthopedic Surgery

Recruiting Phase 2/3
View on ClinicalTrials.gov →
Summary
This clinical trial is a multiple-center, randomized, double-blind, placebo- and active-controlled parallel-group Phase II/III clinical trial, to evaluate the efficacy and safety of HL-1186 Tablets for Postoperative Analgesia in Orthopedic Surgery.
Trial Details
NCT Number NCT07699601
Lead Sponsor Shanghai Huilun Pharmaceutical Co., Ltd.
Conditions Postoperative Pain
Enrollment 330 participants
Start Date 2026-05-09
Primary Completion 2026-10 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-13